TITLE

Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients

AUTHOR(S)
Moore, Gary W.
PUB. DATE
January 2007
SOURCE
Thrombosis Journal;2007, Vol. 5, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Oral anticoagulation compromises conventional lupus anticoagulant (LA) screening assays. Mixing studies can counteract the oral anticoagulant effect but the dilution reduces sensitivity and can generate false negative results. A firm diagnosis can be made from mixing studies when an elevated screen ratio is accompanied by a confirm ratio that generates significant correction to demonstrate phospholipid dependence, but also returns into the reference range, indicating complete normalisation of the oral anticoagulant effect. Taipan snake venom time (TSVT) with Ecarin time (ET) as a confirmatory test comprises an oral anticoagulant insensitive LA detection system and this study investigates the potential impact on detection rates when coupled with mixing studies on standard assays. Methods: Eighty patients known to have LA who were receiving oral anticoagulation were tested with TSVT/ET and 1:1 mixing studies with normal plasma by dilute Russell's viper venom time (DRVVT) and dilute activated partial thromboplastin time (DAPTT) to assess detection rates by single and multiple assays. Results: Thirty three of the 80 samples from known LA positive patients were positive in all three assays and 15 were positive in combinations of DRVVT, DAPTT or TSVT/ET. The remainder were positive in only one assay; 12 by DRVVT, 4 by DAPTT and 16 by TSVT/ET. Although all DRVVT and DAPTT positive mixing studies generated significant correction of the screen ratio by the confirm ratio, not all confirm ratios corrected back into the reference range. This was the case for 87.5% of the DRVVT results, 44.7% of the DAPTT results and 13.3% of the TSVT/ET positive mixing tests. Conclusion: Addition of TSVT/ET screening for LA in orally anticoagulated patients could increase diagnostic efficacy either by detecting antibodies diluted in the mixing tests of conventional assays or those that do not react in DRVVT or DAPTT. Additionally, TSVT/ET can affirm the presence of a LA where conventional assay mixing tests may not have fully counteracted the oral anticoagulant effect but confirmatory test correction suggests the presence of a LA.
ACCESSION #
28810438

 

Related Articles

  • Clinicohematologic Spectrum in Patients with Lupus Anticoagulant. Bhattacharya, M.; Biswas, A.; Kannan, M.; Mishra, P.; Kumar, A.; Choudhary, V. P.; Saxena, R. // Clinical & Applied Thrombosis/Hemostasis;Apr2005, Vol. 11 Issue 2, p191 

    A retrospective analysis of clinicohematologic parameters of 25 patients with lupus anticoagulant was carried out. The hematologic tests included dilute Russel viper venom test (dRWT), kaolin clotting time (KCT), activated partial thromboplastin time, and prothrombin time. The diagnosis of lupus...

  • Circling Coagulation Inhibitors in the Acquired Immunodeficiency Syndrome. Cohen, Alice J.; Philips, Terrence M.; Kessler, Craig M. // Annals of Internal Medicine;Feb86, Vol. 104 Issue 2, p175 

    Presents a study that identified abnormal coagulation profiles in patients with AIDS associated with opportunistic infections and malignancies. Elevation of activated partial thromboplastin times in patients; Presence of lupus-type anticoagulants characterized by rapid prolongations of the...

  • Clinical Utility of the Less Commonly Employed Assays for Lupus Anticoagulant Detection: the Evidence. Moore, Gary W. // Journal of Coagulation Disorders;2010, Vol. 2 Issue 1, p69 

    Accurate detection of persistent antiphospholipid antibodies (aPA) is crucial to the diagnosis of the antiphospholipid syndrome. Lupus anticoagulants (LA) are aPA that are detected by their behavior in coagulation assays, a process that is complicated by marked antibody heterogeneity and...

  • Clinical Utility of the Less Commonly Employed Assays for Lupus Anticoagulant Detection: the Evidence. Moore, Gary W. // Journal of Coagulation Disorders;2010, Vol. 2 Issue 2, p69 

    Accurate detection of persistent antiphospholipid antibodies (aPA) is crucial to the diagnosis of the antiphospholipid syndrome. Lupus anticoagulants (LA) are aPA that are detected by their behavior in coagulation assays, a process that is complicated by marked antibody heterogeneity and...

  • Coagulation Tests and Anti-Phospholipid Antibodies in Patients Positive for Lupus Anticoagulant. Sakakura, Miho; Wada, Hideo; Watanabe, Rika; Mamamuro, Miho; Okugawa, Yoshinaga; Nakasaki, Takahiro; Nakase, Tutomu; Wakita, Yoshihiro; Minamikawa, Kouzou; Mori, Yositaka; Nshikawa, Masakatsu; Shiku, Hiroshi // Clinical & Applied Thrombosis/Hemostasis;Jul2000, Vol. 6 Issue 3, p144 

    We examined activated partial thromboplastin lime, kaolin clotting time, mixing with normal plasma in kaolin clotting time, dilute Russell's viper venom lime, dilute Russell's viper venom time at high lipid concentrations, anti-phospholipid antibodies, and anti-cardiolipin-β2-glycoprotein 1...

  • Differential Effects of Unfractionated Heparin and Low-Molecular-Weight Heparins on Tissue Thromboplastin Inhibition Test. Gerbutavicius, Rolandas; Iqbal, Omer; Messmore, Harry; Hoppensteadt, Debra A.; Demir, Muzaffer; Khan, Erum; Bacher, Peter; Fareed, Jawed // Clinical & Applied Thrombosis/Hemostasis;Oct2000, Vol. 6 Issue 4, p190 

    Circulating anticoagulants are endogenously produced substances that interfere with in vitro tests of coagulation like activated partial thromboplastin time (APTT). and cause prolongation of the clotting times. Evaluation of the abnormal APTT involving various factor assays and mixing studies...

  • aPTT in Heparinized Patients: Influence of the Interval Between Sampling and Testing. Rachakonda, Vikrant; Rachakonda, Leelanand; Belliveau, Robert R. // Clinical & Applied Thrombosis/Hemostasis;Jul1998, Vol. 4 Issue 3, p213 

    Activated partial thromboplastin times(aPTTs) from, 29 whole blood samples were drawn from patients receiving unfractionated heparin through a constant intravenous drip. Three aPTTs were determined for each whole blood sample. The first aPTT was performed on a separate portion of the original...

  • Performance Evaluation of a New Small-Volume Coagulation Monitor: The SmartCheck INR System. Chris Gardiner; Ian Longair; Jennifer Hills; Hannah Cohen; Ian Mackie // American Journal of Clinical Pathology;Mar2008, Vol. 129 Issue 3, p500 

    The SmartCheck INR (Unipath, Bedford, England) is a point-of-care device for professional and patient self-monitoring of oral anticoagulant therapy. It measures the international normalized ratio (INR) and assesses test strip integrity, temperature, and sample quality. No significant differences...

  • Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction. Khan, Haseeb A.; Alhomida, Abdullah S.; Al Rammah, Tamader Y.; Sobki, Samia H.; Ola, Mohammad S.; Khan, Adnan A. // International Journal of Clinical & Experimental Medicine;2013, Vol. 6 Issue 4, p294 

    Prothrombin time (PT) and activated partial thromboplastin time (aPTT) respectively measures the extrinsic and intrinsic pathways of coagulation and are used to determine the bleeding or clotting tendency of blood. We compared PT and aPTT levels in acute myocardial infarction (AMI) patients and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics